Medicure (MCUJF) Change in Accured Expenses (2009 - 2026)
Medicure's (MCUJF) quarterly Change in Accured Expenses came in at -$604511.5 in Q1 2026, down 309.01% year-on-year from $289220.3 in Q1 2025, and down 128.33% quarter-over-quarter from $2.1 million in Q4 2025.
Medicure (MCUJF) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Medicure's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$604511.5 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 309.01% year-over-year to -$604511.5 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 1019.36% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 684.77% from the prior year.
- Change in Accured Expenses fell to -$604511.5 in Q1 2026 per MCUJF's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.1 million in Q4 2025 and bottomed at -$663235.5 in Q3 2022.
- The 5-year median for Change in Accured Expenses is -$88351.8 (2024), against an average of $85097.2.
- Across the five-year window, Change in Accured Expenses slumped 384.94% in 2022 and surged 987.24% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$663235.5 in 2022, then jumped by 196.57% to $640515.0 in 2023, then tumbled by 137.55% to -$240525.3 in 2024, then jumped by 987.24% to $2.1 million in 2025, then sank by 128.33% to -$604511.5 in 2026.
- Per Business Quant, the three latest MCUJF Change in Accured Expenses figures stand at -$604511.5 (Q1 2026), $2.1 million (Q4 2025), and -$467952.9 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -604,511.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -604,511.52 |
| Mar 31, 2026 | -604,511.52 |
| Dec 31, 2025 | 2.13 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | -467,952.94 |
| Sep 30, 2025 | -467,952.94 |
| Jun 30, 2025 | 145,064.21 |
| Jun 30, 2025 | 145,064.21 |
| Mar 31, 2025 | 289,220.34 |
| Mar 31, 2025 | 289,220.34 |
| Dec 31, 2024 | -240,525.31 |
| Dec 31, 2024 | -240,525.31 |
| Sep 30, 2024 | -592,307.16 |
| Sep 30, 2024 | -592,307.16 |
| Jun 30, 2024 | 412,363.27 |
| Jun 30, 2024 | 412,363.27 |
| Mar 31, 2024 | 63,821.74 |
| Mar 31, 2024 | 63,821.74 |
| Dec 31, 2023 | 640,514.98 |
| Dec 31, 2023 | 640,514.98 |